The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.

The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation. J Clin Exp Hematop. 2018 Sep 19; 58(3):107-121.

View in: PubMed

subject areas

Adult
Allografts
Female
Hematopoietic Stem Cell Transplantation
Human T-lymphotropic virus 1
Humans
Kidney Transplantation
Leukemia-Lymphoma, Adult T-Cell
Male
Middle Aged
Retrospective Studies
Spinal Cord Diseases

authors with profiles

Atsushi Doi